Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass

Intensive Care Medicine

Volumn 26, Issue 2, 2000, Pages 188-194

  Haraldsson, A ^a   Kieler Jensen, N ^a   Wadenvik, H ^a   Ricksten, S E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aerosol; Cardiac surgery; Platelet function; Prostacyclin

Indexed keywords

ADENOSINE DIPHOSPHATE; PROSTACYCLIN;

ADULT; AEROSOL; AGED; AORTA VALVE DISEASE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HUMAN; IN VITRO STUDY; INTENSIVE CARE; MALE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION;

EID: 0034109485     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050044     Document Type: Article

References (38)

1. 1. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC (1988) Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 7: 331-336
2. 2. Kieler-Jensen N, Milocco I, Kicksten S-E (1993) Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart Lung Transplant 12: 179-184
3. 3. Radermacher P, Santak B, Wüst H, Tarnow J, Falke KJ (1990) Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72: 238-244
4. 4. Kieler-Jensen N, Houltz E, Milocco I, Ricksten SE (1993) Central hemodynamics and right ventricular function after coronary artery bypass surgery. A comparison of prostacyclin, sodium nitroprusside and nitroglycerin for treatment of postcardiac surgical hypertension. J Cardiothorac Vasc Anesth 7: 555-559
5. 5. Kieler-Jensen N, Lundin S, Ricksten S-E (1995) Vasodilator therapy after heart transplantation. Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1 and sodium nitroprusside. J Heart Lung Transplant 14: 436-443
6. 6. Zapol W, Falke K, Hurford W, Roberts J (1994) Inhaling nitric oxide: a selective pulmonary vasodilator and bronchodilator. Chest 105: 87S-91S
7. 7. Nathorst Westfelt U, Lundin S, Stenquist O (1995) Safety aspects on nitric oxide administration. Acta Anaesthesiol Scand 39 [Suppl. 105]:60-62
8. 8. Samama C, Diaby M, Fellahi J-L, Mdhafar A, Eyraud D, Arock M, et al. (1995) Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 83: 56-65
9. 9. Högman M, Frostell C, Hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341: 1664-1665
10. 10. Moncada S (1983) Biology and therapeutic potential of prostacyclin. Stroke 14: 157-168
11. 11. Haraldsson Å, Kieler-Jensen N, Ricksten S-E (1996) Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamlc study. J Cardiothorac Vasc Anesth 10(7):864-868
12. 12. Walmrath D, Schneider T, Pilch J, Grimminger F, Seegcr W (1993) Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 342: 961-962
13. 13. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Roissant R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82: 1507-1511
14. 14. Walmrath D, Schneider R, Schermuly R, Olschewski H, Grimminger F, Seeger W (1996) Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 153: 991-995
15. 15. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W (1995) Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am J Respir Crit Care Med 151: 724-730
16. 16. Zwissler B, Rank N, Jaenicke U, Schürle B, Welte M, Reichart B et al. (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82: 1512-1516
17. 17. Webb SAR (1996) The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intensive Care Med 22: 353-355
18. 18. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W (1996) Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 124: 820-824
19. 19. Mikhail G, Gibbs JS, Richardson M, Wright G, Khagahni A, Banner N, et al. (1997) An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J 18: 1499-1504
20. 20. Burghuber O, Silberbauer K, Haber P, Sinzinger H, Elliott M, Leithner C (1984) Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration 45: 450-454
21. 21. Hardy C, Bradding P, Robinson C, Holgate T (1988) Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol 64(4):1567-1574
22. 22. Szczeklik A, Gryglewski R, Nizankowska E, Musial J (1978) Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man. Prostaglandins 16: 651-660
23. 2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 22: 426-433
24. 24. DeCaterina R, Lanza M, Manca G, ButiStrata G, Maffei S, Salvatore L (1994) Bleeding time and bleeding: An analysis of the relationship of bleeding time test with parameters of surgical bleeding. Blood 84: 3363-3370
25. 25. Born G (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929
26. 26. Traverso C, Caprini J, Arcelus J (1995) The normal thrombelastogram and its interpretation. Semin Thromb Hemost 21: 7-13
27. 27. Tabachnick B, Fidell L (1989) Profile analysis of repeated measures. In: Tabachnick B (ed) Using multivariate statistics, 2nd edn. Harper Collins, New York
28. 28. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibit platelet aggregation. Nature 263: 663-665
29. 29. Mammen E, Koets M, Washington B, Wolk L, Brown J, Burdick M et al. (1985) Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 11: 281-292
30. 30. Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H et al. (1993) The platelet function defect of cardiopulmonary bypass. Blood 82: 107-117
31. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 154: 1671-1677
32. 32. Ylikorkala O, Saarela E, Viinkka L (1981) Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass. J Cardiovasc Surg 82: 245-247
33. 33. Haraldsson Å, Kieler-Jensen N, Nathorst-Westfelt U, Bergh C, Ricksten S (1998) Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 114: 780-786
34. 2-aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25: 329-340
35. 35. Thomas S, O'Doherty M, Fidler H, Page C, Treacher D, O'Nunan T (1993) Pulmonary deposition of a nebulized aerosol during mechanichal ventilation. Thorax 48: 154-159
36. 36. Spiess B, Tuman K, McCarthy R, DeLaria G, Schillo R, Ivankovich A (1987) Thrombelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 3: 25-30
37. 37. Dogan V, Ovali E, Eti Z, Yayci A, Gö güs Y (1999) The in vitro effects of isoflurane, sevoflurane and propofol on platelet aggregation. Anesth Analg 88: 432-436
38. 38. Hirakata H, Nakamura K, Yokubol B, Toda H, Hatano Y, Urabe N et al. (1999) Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. Anesthesiology 91: 1361-1369